SCHEMBL8347604

SCHEMBL8347604

CC(C)Oc1cccc(C(=O)CCl)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.54
MEN1 O00255 2/20 0.54
GAA P10253 1/20 0.54
HTT P42858 1/20 0.54
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
ALDH1A1 P00352 4/20 0.48
TRPA1 O75762 1/20 0.48
MAPK1 P28482 1/20 0.48
GSK3B P49841 1/20 0.48
HIF1A Q16665 1/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
LMNA P02545 3/20 0.47
NPC1 O15118 3/20 0.47
RAB9A P51151 3/20 0.47
KAT6A Q92794 2/20 0.47
ALOX12 P18054 1/20 0.47
KDM4E B2RXH2 4/20 0.47
NSD2 O96028 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1416792 0.85 KMT2A (0.55) KMT2AMEN1GAAHTTRXRA
SCHEMBL27916078 0.85 KMT2A (0.55) KMT2AMEN1GAAHTTRXRA
SCHEMBL14518786 0.83 KMT2A (0.54) KMT2AMEN1GAAHTTRXRA
SCHEMBL637341 0.83 KMT2A (0.54) KMT2AMEN1GAAHTTRXRA
SCHEMBL2379240 0.83 CES2 (0.65) KMT2AMEN1HTTALDH1A1TRPA1
SCHEMBL16937850 0.82 MEN1 (0.52) KMT2AMEN1GAAHTTRXRA
SCHEMBL1167621 0.81 KMT2A (0.58) KMT2AMEN1GAAHTTRXRA
SCHEMBL11700532 0.81 KMT2A (0.61) KMT2AHTTALDH1A1TRPA1MAPK1
SCHEMBL22718331 0.81 KMT2A (0.51) KMT2AMEN1GAAHTTRXRA
SCHEMBL30474528 0.81 KMT2A (0.51) KMT2AMEN1GAAHTTRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109912436-A A kind of synthetic method of oxadiazon intermediate 安徽省化工研究院 2019-06-21 CN disclosed
US-5861416-A TREATMENT OF ASTHMA OR COUGH MERRELL PHARMACEUTICALS INC. (US) 1999-01-19 US disclosed
US-5824690-A TREATING ASTHMA, COUGH HOECHST MARION ROUSSEL INC. (US) 1998-10-20 US disclosed
EP-0696280-B1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL PHARMA INC (US) 1997-09-24 EP disclosed
US-5661160-A ADMINISTERING AN ANTITUSSIVE AGENT FOR TREATING COUGH; TACHYKININ ANTAGONISM, SUBSTANCE P AND NEUROKININ A ANTAGONISM MERRELL PHARMACEUTICALS INC. (US) 1997-08-26 US disclosed
US-5648366-A TACHYKININ ANTAGONISTS USEFUL IN TREATING ASTHMA MERRELL PHARMACEUTICALS INC. (US) 1997-07-15 US disclosed
US-5635510-A TACHYKININ (ESPECIALLY SUBSTANCE P AND NEUROKININ A) ANTAGONISTS; ANTIINFLAMMATORY AGENTS, ANALGESICS; NERVOUS SYSTEM DISORDERS; BRONCHODILATOR AGENTS MERRELL PHARMACEUTICALS INC. (US) 1997-06-03 US disclosed
EP-0696280-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMA (US) 1996-02-14 EP disclosed
WO-1994026735-A1 SUBSTITUTED PYRROLIDIN-3-YL-ALKYL-PIPERIDINES USEFUL AS TACHYKININ ANTAGONISTS MERRELL DOW PHARMACEUTICALS INC. (US) 1994-11-24 WO disclosed